These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1313320)

  • 1. Enalapril to lisinopril: economic impact of a voluntary angiotensin-converting enzyme-inhibitor substitution program in a staff-model health maintenance organization.
    McDonough KP; Weaver RH; Viall GD
    Ann Pharmacother; 1992 Mar; 26(3):399-404. PubMed ID: 1313320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of switching hypertensive patients from enalapril maleate to lisinopril.
    Lindgren-Furmaga EM; Schuna AA; Wolff NL; Goodfriend TL
    Am J Hosp Pharm; 1991 Feb; 48(2):276-9. PubMed ID: 1848392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversions from captopril to lisinopril at a dosage ratio of 5:1 result in comparable control of hypertension.
    Gill TH; Hauter F; Pelter MA
    Ann Pharmacother; 1996 Jan; 30(1):7-11. PubMed ID: 8773158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular Dysfunction.
    Scott WG; Scott HM
    Pharmacoeconomics; 1996 Feb; 9(2):156-67. PubMed ID: 10160094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
    Bourgault C; Elstein E; Le Lorier J; Suissa S
    CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of enalapril maleate in the management of congestive heart failure in Australia.
    Butler JR; Fletcher PJ
    Aust N Z J Med; 1996 Feb; 26(1):89-95. PubMed ID: 8775534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD; Goedde M; Berger K; Kiowski W
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.
    Glick H; Cook J; Kinosian B; Pitt B; Bourassa MG; Pouleur H; Gerth W
    J Card Fail; 1995 Dec; 1(5):371-80. PubMed ID: 12836712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
    Espinel CH; Williams JL; Coughlin SS
    Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
    Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
    Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.
    Sculpher MJ; Poole L; Cleland J; Drummond M; Armstrong PW; Horowitz JD; Massie BM; Poole-Wilson PA; Ryden L
    Eur J Heart Fail; 2000 Dec; 2(4):447-54. PubMed ID: 11113723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA; Murray KM
    Clin Pharm; 1988 Sep; 7(9):659-69. PubMed ID: 2853660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose lisinopril in heart failure: economic considerations.
    Ess SM; Lüscher TF; Szucs TD
    Cardiovasc Drugs Ther; 2002 Jul; 16(4):365-71. PubMed ID: 12652106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness analysis of the treatment with enalapril of chronic heart failure in Spain].
    Antoñanzas Villar F; Antón Botella F; Echevarría Echarri L
    Gac Sanit; 1996; 10(54):135-42. PubMed ID: 8991882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents].
    Savenkov MP; Ivanov SN; Brodskaia SA
    Ter Arkh; 2001; 73(9):27-31. PubMed ID: 11642076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
    Dezii CM
    Manag Care; 2000 Sep; 9(9 Suppl):2-6. PubMed ID: 11729417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisinopril, a new angiotensin converting enzyme inhibitor.
    Arzubiaga C; Beck NA
    Am J Med Sci; 1992 May; 303(5):340-4. PubMed ID: 1316080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.